Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Czech Republic09795720.3Filed on 2009-12-18
Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Cyprus09795720.3Filed on 2009-12-18
Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Switzerland09795720.3Filed on 2009-12-18
Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Bulgaria09795720.3Filed on 2009-12-18
Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Belgium09795720.3Filed on 2009-12-18
Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis Austria09795720.3Filed on 2009-12-18
Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS) Read more about Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS) US Application 16/000,965Filed on 2018-06-06
METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS Read more about METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS US Application 16/132,852Filed on 2018-09-17
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists Read more about 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists Ireland14750663.8Filed on 2016-01-22
11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists Read more about 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists United Kingdom14750663.8Filed on 2016-01-22